Hibino, Emi http://orcid.org/0000-0002-0846-8842
Hiroaki, Hidekazu http://orcid.org/0000-0003-1621-5893
Funding for this research was provided by:
the Japan Science and Technology Agency, A-step Feasibility Study Program (AS262Z01275Q, AS242Z00566Q)
Japan Agency for Medical Research and Development (20 lm0203011-j0002)
Aichi Cancer Research Foundation
Article History
Received: 17 September 2021
Accepted: 14 November 2021
First Online: 11 January 2022
Declarations
:
: This article does not contain any studies with human participants or animals performed.
: Not applicable.
: Not applicable.
: H. H. is the founder of a Nagoya University-based spinoff startup company, BeCellBar LLC. E. H. declares that they have no conflicts of interest regarding the contents of this article.